Page 47 - Colitis Foundation News Today

A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine researchers.

/PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ:...

/PRNewswire/ -- AbbVie (NYSE:ABBV) today announced it has submitted an application to the European Medicines Agency (EMA) seeking approval for risankizumab...

/PRNewswire/ -- AbbVie (NYSE:ABBV) today announced it has submitted an application to the European Medicines Agency (EMA) seeking approval for risankizumab...

AbbVie Submits Application for Risankizumab (SKYRIZI®) in Moderate to Severe Crohn's Disease to European Medicines Agency (EMA) - read this article along with other careers information, tips and advice on BioSpace

Xplor Announces 2021 Lifetime Achievement Award

The Lifetime Achievement Award was established in 2007 and is given to an individual, or individuals, whose efforts and contributions have significantly changed the course and development of the digital document industry.

Suzanne Hellums, an artist who has Crohn’s disease, blends her love of chemistry and art to create stunning pictures and prints for ArtLifting.

Read the latest Inflammatory Bowel Disease headlines, on NewsNow: the one-stop shop for Inflammatory Bowel Disease news

Millions of people in the U.S. suffer from inflammatory bowel diseases, ulcerative colitis and Crohn's disease. How does IBD affect running?